Specifically, while GM-CSF was increased in COVID-19 patients across all severity strata relative to HVs, G-CSF was increased only in patients with critical disease; SCF was increased only in patients with moderate disease (Supplemental Figure 9 and Supplemental Table 3). Here, CSF2 is linked to COVID-19.